🇺🇸 FDA
Patent

US 7319091

Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body, and the cloning of full length cDNA thereof

granted A61KA61K38/00A61P

Quick answer

US patent 7319091 (Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body, and the cloning of full length cDNA thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jan 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/00, A61P, A61P31/00